Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ouyang Xie"'
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
AimsAssessing the cost-effectiveness of Nivolumab with Gemcitabine–Cisplatin for Advanced Urothelial Carcinoma (aUC) treatment from the perspective of Chinese payers.MethodsA Markov model assessed economic outcomes, estimating health outcomes in qu
Externí odkaz:
https://doaj.org/article/29ca7c6012b541529e1081a680969feb
Autor:
Andong Li, Meiyu Wu, Ouyang Xie, Heng Xiang, Kehui Meng, Chongqing Tan, Long Wang, Xiaomin Wan
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Background and objectiveThe EV-302 trial found that the combination of enfortumab vedotin (EV) with pembrolizumab significantly improved survival for patients with metastatic urothelial carcinoma (mUC). However, given the high cost of the drugs, ther
Externí odkaz:
https://doaj.org/article/b4ce46e9beac4f228c31b672efce7fa8
Publikováno v:
BMC Medicine, Vol 21, Iss 1, Pp 1-11 (2023)
Abstract Background China has one of the highest numbers of liver disease cases in the world, including 6.4 million cirrhosis associated with alcohol-related liver disease (ALD) cases. However, there is still a lack of urgent awareness about the grow
Externí odkaz:
https://doaj.org/article/b41f51cd651d4642be696ed3f090a0db